This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Ernst E, Cassileth BR . The prevalence of complementary/alternative medicine in cancer: a systematic review. Cancer 1998; 83: 777–782.
Andersson BS, Thall PF, Madden T, Couriel D, Wang X, Tran HT et al. Busulfan systemic exposure relative to regimen-related toxicity and acute graft-versus-host disease: defining a therapeutic window for i.v. BuCy2 in chronic myelogenous leukemia. Biol Blood Marrow Transplant 2002; 8: 477–485.
Ltd FMD Flora Flor-Essence Herbal Tea Blend Description (cited 2013 July 22). Available from http://www.florahealth.com/product_conditions_usa.cfm?conditions_id=4&prod_id=211.
Leonard BJ, Kennedy DA, Cheng FC, Chang KK, Seely D, Mills E . An in vivo analysis of the herbal compound essiac. Anticancer Res 2006; 26: 3057–3063.
Seely D, Kennedy DA, Myers SP, Cheras PA, Lin D, Li R et al. In vitro analysis of the herbal compound Essiac. Anticancer Res 2007; 27: 3875–3882.
Lin SC, Chung TC, Lin CC, Ueng TH, Lin YH, Lin SY et al. Hepatoprotective effects of Arctium lappa on carbon tetrachloride- and acetaminophen-induced liver damage. Am J Chinese Med 2000; 28: 163–173.
Guo Z, Smith TJ, Wang E, Sadrieh N, Ma Q, Thomas PE et al. Effects of phenethyl isothiocyanate, a carcinogenesis inhibitor, on xenobiotic-metabolizing enzymes and nitrosamine metabolism in rats. Carcinogenesis 1992; 13: 2205–2210.
Hassan M, Oberg G, Ehrsson H, Ehrnebo M, Wallin I, Smedmyr B et al. Pharmacokinetic and metabolic studies of high-dose busulphan in adults. Eur J Clin Pharmacol 1989; 36: 525–530.
Buggia I, Zecca M, Alessandrino EP, Locatelli F, Rosti G, Bosi A et al. Itraconazole can increase systemic exposure to busulfan in patients given bone marrow transplantation. GITMO (Gruppo Italiano Trapianto di Midollo Osseo). Anticancer Res 1996; 16: 2083–2088.
Freytes CO, Toro JJ, Yeh RF, Stadtmauer EA, Ratanatharathorn V, Akpek G et al. Pharmacokinetics and safety of once-daily intravenous busulfan with bortezomib in patients with relapsed multiple myeloma undergoing a second autologous hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2012; 18: S253.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
Dr Barta receives research funding from Otsuka Pharmaceuticals. The remaining authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Carter, J., Yeh, R., Braunschweig, I. et al. Unreported use of an herbal supplement resulting in decreased clearance of intravenous busulfan in a patient undergoing auto-SCT. Bone Marrow Transplant 49, 313–314 (2014). https://doi.org/10.1038/bmt.2013.169
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2013.169
This article is cited by
-
HDI Highlighter, The First Intelligent Tool to Screen the Literature on Herb–Drug Interactions
Clinical Pharmacokinetics (2022)
-
Busulfan/herbal medicines interaction
Reactions Weekly (2014)